Events & Conferences
The JMP Securities Hematology and Oncology Summit (Virtual)
Our CEO, Jean-Paul Kress, M.D., will present the company during a Webcast.
Date: Tuesday, December 5
Time: 12.30pm ET
ASH 2023 Investor Event with Medical Experts
The event will highlight pelabresib’s potential in first-line myelofibrosis with a comprehensive overview of the Phase 3 MANIFEST-2 trial results, which will be presented during an oral presentation at ASH 2023 on Sunday December 10. There will be live presentations from and a Q&A opportunity with MorphoSys management and leading medical experts.
Monday, December 11, 7:00 a.m. – 8:30 a.m. PST (10:00 a.m. - 11:30 a.m. EST / 4:00 p.m. - 5:30 p.m. CET)
42nd Annual J.P. Morgan Healthcare Conference
Our CEO, Jean-Paul Kress, M.D., will present MorphoSys during a Webcast.
Date: Wednesday, January 10, 2024
Time: 3.00 - 3.40pm PST